Li Hu Selected Research

Inverted Papilloma

4/2020	Low prevalence of human papillomavirus infection in sinonasal inverted papilloma and oncocytic papilloma.
12/2019	ErbB1 and ErbB2 overexpression in patients with sinonasal inverted papilloma and inverted papilloma with squamous cell carcinoma in China.
8/2014	The role of tissue factor pathway inhibitor-2 in malignant transformation of sinonasal inverted papilloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Hu Research Topics

Disease

43	Neoplasms (Cancer) 04/2022 - 10/2011
20	Pain (Aches) 12/2022 - 02/2013
12	Inflammation (Inflammations) 12/2022 - 12/2014
7	Angiofibroma 01/2022 - 10/2011
6	Virus Diseases (Viral Diseases) 03/2022 - 01/2019
6	Rhinosinusitis 01/2022 - 01/2012
6	Glioma (Gliomas) 01/2022 - 01/2014
6	Hyperalgesia 01/2022 - 08/2008
5	Cicatrix (Scar) 12/2022 - 12/2016
5	Infections 06/2022 - 02/2013
5	Breast Neoplasms (Breast Cancer) 04/2022 - 05/2019
5	Hypoxia (Hypoxemia) 01/2022 - 06/2017
5	Carcinogenesis 12/2021 - 12/2012
5	Insulin Resistance 09/2021 - 01/2018
5	Allergic Rhinitis 01/2021 - 12/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2015
4	Nasal Polyps (Nasal Polyp) 01/2022 - 04/2017
4	Hypertension (High Blood Pressure) 12/2021 - 01/2014
4	Body Weight (Weight, Body) 03/2021 - 12/2011
4	COVID-19 01/2021 - 01/2020
4	Schizophrenia (Dementia Praecox) 01/2018 - 10/2010
4	Wounds and Injuries (Trauma) 10/2017 - 03/2013
3	Nasopharyngeal Carcinoma 01/2022 - 01/2020
3	Neuralgia (Stump Neuralgia) 01/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2019
3	Neuroinflammatory Diseases 12/2021 - 01/2020
3	Melanoma (Melanoma, Malignant) 12/2021 - 01/2018
3	Obesity 09/2021 - 10/2018
3	Multiple Sclerosis 01/2021 - 01/2020
3	Stroke (Strokes) 01/2021 - 02/2020
3	Fibrosis (Cirrhosis) 01/2021 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2014
3	Inverted Papilloma 04/2020 - 08/2014
3	Cognitive Dysfunction 01/2020 - 01/2013
3	Hemorrhage 11/2019 - 09/2014
3	Atrophy 02/2016 - 01/2015
2	Osteoporosis 12/2022 - 01/2022
2	Seizures (Absence Seizure) 06/2022 - 01/2021
2	Epilepsy (Aura) 06/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2022 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2021
2	Pulmonary Hypertension 01/2022 - 10/2020
2	Nausea 12/2021 - 01/2021
2	Vomiting 12/2021 - 01/2021
2	Chronic Pain 06/2021 - 06/2021

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2012
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2010
10	CytokinesIBA 01/2022 - 09/2014
9	Analgesics (Analgesic Drugs)IBA 01/2022 - 06/2017
8	Messenger RNA (mRNA)IBA 12/2022 - 02/2014
6	MicroRNAs (MicroRNA)IBA 05/2022 - 08/2014
6	Transcription Factors (Transcription Factor)IBA 03/2022 - 02/2016
6	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2014
6	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
5	Therapeutic UsesIBA 06/2022 - 01/2015
4	Peptides (Polypeptides)IBA 01/2022 - 10/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
4	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
4	Neurotransmitter Agents (Neurotransmitter)IBA 12/2021 - 10/2010
4	Interleukin-6 (Interleukin 6)IBA 09/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 12/2022 - 01/2013
3	Death-Associated Protein KinasesIBA 06/2022 - 01/2021
3	EnzymesIBA 05/2022 - 09/2016
3	Neoplasm Antigens (Tumor Antigens)IBA 03/2022 - 10/2018
3	Protein Isoforms (Isoforms)IBA 03/2022 - 12/2012
3	AntigensIBA 01/2022 - 12/2021
3	Circular RNAIBA 01/2022 - 01/2019
3	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2015
3	Biological ProductsIBA 06/2021 - 10/2011
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2021 - 10/2011
3	InterleukinsIBA 01/2020 - 01/2015
3	ParaquatIBA 08/2018 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018 - 10/2011
3	CollagenIBA 10/2017 - 03/2015
3	Insulin-Like Growth Factor I (IGF-1)IBA 02/2016 - 01/2015
3	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2012 - 10/2010
2	Glutamic Acid (Glutamate)FDA Link 06/2022 - 10/2010
2	Interferon Type IIBA 01/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2019
2	Chimeric Antigen ReceptorsIBA 01/2022 - 10/2018
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 11/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2019
2	serum-glucocorticoid regulated kinaseIBA 01/2022 - 09/2021
2	Nicotine FDA Link 12/2021 - 12/2020
2	OvalbuminIBA 12/2021 - 01/2021
2	ORALIT (ORS)IBA 10/2021 - 04/2012
2	transcription factor NF-AT c3IBA 09/2021 - 10/2018
2	Hemoglobins (Hemoglobin)IBA 07/2021 - 06/2020

Therapy/Procedure

24	Therapeutics 03/2022 - 03/2012
10	Immunotherapy 03/2022 - 10/2018
6	Lasers (Laser) 12/2022 - 01/2012
6	Radiotherapy 01/2022 - 10/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2017
3	Analgesia 06/2021 - 01/2017
3	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021 - 06/2017
2	Length of Stay 06/2022 - 08/2021
2	Sclerotherapy 03/2022 - 03/2020
2	Transplantation 01/2022 - 12/2021